You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Harvard Business School
Boehringer Ingelheim
Medtronic
McKesson

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Bacillus anthracis - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for bacillus anthracis

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Damietta UniversityPhase 2
Kafrelsheikh UniversityPhase 2
BayerN/A

See all bacillus anthracis clinical trials

Recent Litigation for bacillus anthracis

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
MEDIZONE INTERNATIONAL, INC.2018-05-08
XtraLight Manufacturing, Ltd.2018-04-11
NYU Winthrop Hospital v. Microbion Corporation2017-10-20

See all bacillus anthracis litigation

PTAB Litigation
PetitionerDate
2018-07-27

See all bacillus anthracis litigation

Patent Text Search: US Patents for bacillus anthracis

These patents were identified by searching patent claims

Supplementary Protection Certificates for bacillus anthracis

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013 00057 Denmark   Start Trial PRODUCT NAME: LEVENDE MODIFICERET VACCINIA VIRUS ANKARA; REG. NO/DATE: EU/1/13/855 20130731
C1012 France   Start Trial PRODUCT NAME: ERAVACYCLINE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/18/1312 20180924
2019000000039 Italy   Start Trial PRODUCT NAME: ERAVACICLINA DICLORIDRATO(XERAVA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1312, 20180924
2013 00057 Denmark   Start Trial PRODUCT NAME: LEVENDE MODIFICERET VACCINIA VIRUS ANKARA; REG. NO/DATE: EU/1/13/855 20130805
13C/065 Belgium   Start Trial PRODUCT NAME: VIRUS VIVANT MODIFIE DE LA VACCINE ANKARA; AUTHORISATION NUMBER AND DATE: EU/1/13/855 20130805
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
McKinsey
Merck
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.